Skip to content

Welcome to Discover Pharma! Today is : November 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

lung cancer drug development Pic suggestion: A clinical research lab setting showing scientists reviewing patient data or working with oncology lab equipment

  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    DeuterOncology presents phase 1 data for do-2 MET inhibitor showing tumour control with low side effects

    DeuterOncology, a clinical-stage biotech company developing deuterated cancer therapies, has [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Wiley launches online platform for spectral data and compound identification
    Categories: Digital & Data, Research & Development
  • iOnctura to present roginolisib data in immunotherapy-resistant lung cancer
    Categories: Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Lonza expands bioconjugation manufacturing capacity for ADCs
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top